Jamie L. Miller, Pharm.D., BCPS

Associate Professor

Department of Pharmacy: Clinical and Administrative Sciences

Phone (405) 271-6878 x47296

Email jamie-miller@ouhsc.edu


Education & Experience

Doctor of Pharmacy in Pharmacy

Southwestern Oklahoma State University College of Pharmacy,, Weatherford, OK

2006

PGY2 Pediatric Residency (Chief Resident) in Pediatric

OU College of Pharmacy, OKC, OK

ASHP-Accredited


2008

PGY1 Pharmacy Practice Residency in Pharmacy

OU College of Pharmacy, OKC, OK

ASHP-Accredited


2007


Publications & Presentations

1 2 3 4 > >>
  1. Capino A C, Johnson P N, Williams P, Anderson M P, Bedwell S, Miller J L. A pilot study comparing the Modified Finnegan Scoring System versus an adjusted scoring system criteria for infants with iatrogenic opioid abstinence syndrome status-post cardiothoracic surgery. Journal of Pediatric Pharmacology and Therapeutics. In Press
  2. Miller J L, Ernst K, Neely S, Stephens K, Parker P, Skrepnek G H, Johnson P N. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. Journal of Opioid Management. 2019
  3. Miller J L, Johnson P N, White B P, Neely S, Chaaban H, Kassa N, Welliver, Sr R C. Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit. The Pediatric infectious disease journal. 2018
  4. Fox A, Skrepnek G H, Miller J L, Schwier N C, Ripley T L. Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. American Journal of Cardiovascular Drugs . 2018
  5. Allen H C, Garbeb M C, Lees J, Azizb N, Chaaban H, Miller J L, Johnson P N, DeLeon S. Off-label drug use in children, more common than we think: A systematic review of the literature. Journal of Oklahoma State Medical Association. 2018; 10 : 758-765
1 2 3 4 > >>



Grants

  • Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. 2018.
  • Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. 2015.
  • Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. 2015.
  • Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. 2014.
  • Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. 2000.